iBio Inc.

AI Score

0

Unlock

2.87
-0.11 (-3.69%)
At close: Jan 28, 2025, 2:54 PM

iBio Statistics

Share Statistics

iBio has 9.15M shares outstanding. The number of shares has increased by 162.59% in one year.

Shares Outstanding 9.15M
Shares Change (YoY) n/a
Shares Change (QoQ) 6.1%
Owned by Institutions (%) n/a
Shares Floating 8.90M
Failed to Deliver (FTD) Shares 7.00K
FTD / Avg. Volume 5.04%

Short Selling Information

The latest short interest is 255.75K, so 2.8% of the outstanding shares have been sold short.

Short Interest 255.75K
Short % of Shares Out 2.8%
Short % of Float 2.8%
Short Ratio (days to cover) 2.41

Valuation Ratios

The PE ratio is -0.31 and the forward PE ratio is -1.55.

PE Ratio -0.31
Forward PE -1.55
PS Ratio 34.22
Forward PS 161
PB Ratio 0.36
P/FCF Ratio -0.41
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

iBio Inc. has an Enterprise Value (EV) of 20.24M.

EV / Earnings -0.81
EV / Sales 89.97
EV / EBITDA -1.44
EV / EBIT -1.22
EV / FCF -1.08

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.21.

Current Ratio 4.08
Quick Ratio 4.08
Debt / Equity 0.21
Total Debt / Capitalization 17.3
Cash Flow / Debt -4.16
Interest Coverage -96.71

Financial Efficiency

Return on equity (ROE) is -1.17% and return on capital (ROIC) is -64.51%.

Return on Equity (ROE) -1.17%
Return on Assets (ROA) -0.87%
Return on Capital (ROIC) -64.51%
Revenue Per Employee 14.06K
Profits Per Employee -1.56M
Employee Count 16
Asset Turnover 0.01
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by 156.52% in the last 52 weeks. The beta is -3.37, so iBio 's price volatility has been lower than the market average.

Beta -3.37
52-Week Price Change 156.52%
50-Day Moving Average 2.57
200-Day Moving Average 2.26
Relative Strength Index (RSI) 61.83
Average Volume (20 Days) 138.80K

Income Statement

In the last 12 months, iBio had revenue of 225.00K and earned -24.91M in profits. Earnings per share was -6.5.

Revenue 225.00K
Gross Profit 225.00K
Operating Income -16.63M
Net Income -24.91M
EBITDA -14.02M
EBIT -16.63M
Earnings Per Share (EPS) -6.5
Full Income Statement

Balance Sheet

The company has 14.21M in cash and 4.46M in debt, giving a net cash position of 9.75M.

Cash & Cash Equivalents 14.21M
Total Debt 4.46M
Net Cash 9.75M
Retained Earnings -313.85M
Total Assets 24.52M
Working Capital 8.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.55M and capital expenditures -210.00K, giving a free cash flow of -18.76M.

Operating Cash Flow -18.55M
Capital Expenditures -210.00K
Free Cash Flow -18.76M
FCF Per Share -4.9
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -7.39K% and -11.07K%.

Gross Margin 100%
Operating Margin -7.39K%
Pretax Margin -6.86K%
Profit Margin -11.07K%
EBITDA Margin -6.23K%
EBIT Margin -7.39K%
FCF Margin -8.34K%

Dividends & Yields

IBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -220.34%
FCF Yield -69.52%
Dividend Details

Analyst Forecast

The average price target for IBIO is $5, which is 69.5% higher than the current price. The consensus rating is "Buy".

Price Target $5
Price Target Difference 69.5%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on Nov 29, 2023. It was a backward split with a ratio of 1:20.

Last Split Date Nov 29, 2023
Split Type backward
Split Ratio 1:20

Scores

Altman Z-Score -17.15
Piotroski F-Score 4